Francis, J., Zvada, S.P., Denti, P., Hatherill, M., Charalambous, S., Mungofa, S., Dawson, R., Dorman, S., Gupte, N., Wiesner, L. and Jindani, A., 2019. Arylacetamide deacetylase (AADAC) gene polymorphism and HIV infection affect the exposure of Rifapentine: a population pharmacokinetics analysis. Antimicrobial Agents and Chemotherapy, pp.AAC-01964. [Epub ahead of print]
Arylacetamide deacetylase (AADAC) gene polymorphism and HIV infection affect the exposure of Rifapentine: a population pharmacokinetics analysis.
- Journal Articles
